ADVERTISEMENT
See Inside How Drug Company Money Is Undermining Science

conflicting interests, drug research, drug companies,

To what degree do financial entanglements influence the judgment of scientists? To find out, researchers at the Mayo Clinic in Rochester, Minn., focused on the diabetes drug rosiglitazone, which a meta-analysis had linked to increased risk of heart attacks. They examined articles that cited the meta-analysis or a subsequently released report on a large trial of rosiglitazone and found that scientists with a conflict of interest were more likely to view the drug favorably. “There was a clear and strong link between the orientation of authors' expressed views on the rosiglitazone controversy and their financial conflicts of interest with pharmaceutical companies,” the report determined.

conflicting interests, drug research, drug companies,



SOURCE: ASSOCIATION BETWEEN INDUSTRY AFFILIATION AND POSITION ON CAR DIOVASCU LAR RISK WITH ROS IGLITAZONE: CROSS SECTIONAL SYSTEMATIC REVIEW, BY AMY T. WANG, CHRISTOPHER P. MCCOY, MOHAMMAD HASSA N MURA D AND VICTOR M. MONTORI, IN BMJ, VOL. 340, NO. 7750; APRIL 10, 2010

is-drug-research-trustworthy_3.jpg

This is only a preview. Get the rest of this article now!

Select an option below:

Customer Sign In

*You must have purchased this issue or have a qualifying subscription to access this content


It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com.
Click here to access this article in its entirety through site license access.

Share this Article:

Comments

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Scientific American Holiday Sale

Give a Gift &
Get a Gift - Free!

Give a 1 year subscription as low as $14.99

Subscribe Now! >

X

Email this Article

X